CLYM — Climb Bio Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual balance sheet for Climb Bio, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	20.5	136	124	107	151
Net Total Receivables	—	—	—	—	1.12
Prepaid Expenses
Total Other Current Assets
Total Current Assets	22	148	134	110	155
Net Property, Plant And Equipment	—	—	0.471	0.199	0.49
Other Long Term Assets
Total Assets	24.6	173	135	110	217
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	3.06	6.04	6.1	2.83	4.93
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	3.06	6.04	6.28	2.87	5.31
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	21.6	167	129	108	212
Total Liabilities & Shareholders' Equity	24.6	173	135	110	217
Total Common Shares Outstanding
Total Preferred Shares Outstanding